Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rite Aid Corporation (RAD), Walgreen Company (WAG), GNC Holdings Inc (GNC): Has This Drugstore Chain Found a Winning Strategy?

Rite Aid Corporation (NYSE:RAD) has spent much of the past decade weighed down by a heavy debt load that has made competing against industry leader Walgreen Company (NYSE:WAG) very difficult.  However, the company has found momentum, not to mention better results, by positioning itself as a health and wellness outlet for customers.  According to a 2012 RAND Health study, wellness programs are the rage in corporate America, with half of surveyed companies offering wellness promotion programs.  Likely, companies are trying to keep their employee base healthy in order to promote maximum productivity.  So, can investors find value in this story?

Rite Aid Corporation

What’s the value?

Rite Aid Corporation (NYSE:RAD) has a solid operating position as the #3 drugstore chain, trailing only Walgreen Company (NYSE:WAG) and CVS, with over 4,600 stores around the country.  As with its competitors, Rite Aid Corporation (NYSE:RAD) gets most of its revenue from prescription drug sales, accounting for 68% of sales, although it does offer almost 3,000 items in general merchandise categories.  Given its front-line position in the drug distribution system, Rite Aid has rebranded itself as a health store, capable of providing a range of services including prescription management, wellness advice, and non-emergency medical treatment.

In its latest fiscal year, Rite Aid Corporation (NYSE:RAD)’s financial turnaround made noticeable improvement.  While the company’s sales were down marginally, its adjusted operating income increased 19.7% versus the prior year.  Top-line growth was negatively affected by having fewer stores in operation, as well as comparable store declines in its prescription drug sales, an area which continues to be hurt by a shift to lower-priced generic drugs.  On the upside, Rite Aid Corporation (NYSE:RAD)’s move to a wellness format in its stores, with 800 store conversions in 2012, is allowing it to sell more higher-margin, wellness-based services, including flu immunizations that enjoyed a 60% volume increase over the prior year.

Perhaps one of Rite Aid Corporation (NYSE:RAD)’s best moves was partnering with retail health giant GNC Holdings Inc (NYSE:GNC) for store-within-a-store shops that leverage GNC Holdings Inc (NYSE:GNC)’s strong brand name in the vitamins and nutritional supplements area.  There are currently over 2,100 shops in Rite Aid’s national network, roughly 47% of its overall store base, with plans to roll out the format to additional stores in the future.  The partnership is also a symbiotic one, creating low-cost growth opportunities for GNC Holdings Inc (NYSE:GNC).  In FY2013, the wholesale segment has been GNC Holdings Inc (NYSE:GNC)’s fastest growing unit, with sales up 15.2%, as well as generating the company’s highest segment operating margin.

Going global

Of course, Rite Aid still has work to do to chase down industry leader Walgreen Company (NYSE:WAG), whose operating margin of 4.8% in FY2012 was nearly double that of Rite Aid.  The company is similarly positioning itself for growth in the wellness area with a larger portfolio of in-store clinics, usually staffed by a nurse practitioner, that offer comparable services to Rite Aid, including prescription management and education.  Walgreen Company (NYSE:WAG) has also bet big on a global expansion of its operating footprint, with its 2012 multi-billion dollar acquisition of a major stake in Alliance Boots, the U.K.-based operator of over 3,000 health and wellness stores around the world.

In FY2013, Walgreen Company (NYSE:WAG) has posted mixed results, as it continues to try to win back customers that left for other pharmacies during the company’s temporary spat with benefits giant Express Scripts in 2012.  For the period, Walgreen reported flat sales growth and a 7.2% decline in operating income compared to the prior-year period.  Like Rite Aid, Walgreen Company (NYSE:WAG) has been negatively affected by declining comparable store sales in the prescription drug area, down 4.2% for the period, as consumers and their payors increasingly move toward filling prescriptions with generic equivalents.  However, the company’s initiatives, like its Well Experience pilot store format, should provide long-term growth opportunities as Walgreen positions itself as a trusted health advisor, rather than as just a middleman in the drug distribution network.

The bottom line

Despite a hefty debt load, which tips the scales near $6 billion, Rite Aid Corporation (NYSE:RAD) is on the right path with its GNC Holdings Inc (NYSE:GNC) partnership and its focus on selectively trimming unprofitable stores from its network.Given the federal health care reform’s focus on employer incentives for wellness activities, the drugstore chains look well positioned for a greater role in the proactive management of its customers’ health.  While it is unlikely to unseat Walgreen’s for overall industry leadership, Rite Aid should be one of the industry’s winners and belongs on investors’ watchlists.

The article Has This Drugstore Chain Found a Winning Strategy? originally appeared on and is written by Robert Hanley.

Robert Hanley owns shares of Rite Aid and GNC. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.